Websites hosted on 69.63.141.107

HealthCare Ventures is a leading life science venture capital firm investing in pre-clinical or early clinical stage, focused companies with potential to transform patient care.

Depomed is a growth – oriented specialty pharmaceutical company that develops and commercializes innovative branded products that address unmet medical needs.

Catalyst is a clinical-stage biopharmaceutical company leveraging exceptional science to discover and develop essential medicines.

LTC is a real estate investment trust that invests in private pay seniors housing and healthcare properties. The company’s portfolio currently includes over 200 assisted living, memory care, skilled nursing and range-of-care facilities in over 30 states.

The Bluefield Project was established in 2010 to fund research directed towards curing frontotemporal dementia (FTD). FTD is a devastating, early-onset degenerative brain disease and is recognized as a common cause of dementia in people under the age of 60 years.

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer.

Depomed is a growth – oriented specialty pharmaceutical company that develops and commercializes innovative branded products that address unmet medical needs.

PKDW is a year round, Spanish bilingual preschool operated by the PREFund. PKDW provides high quality preschool services to the working families of San Francisco's Potrero Hill community.

Ultragenyx is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. Founded in 2010, the company has rapidly built a diverse portfolio of product candidates with the potential to address diseases for which the unmet medical need is high, the biology for treatment is clear, and for which there are no approved therapies.

Acerta Pharma is a leader in the field of covalent binding technology and is applying this technology to create novel, highly selective therapies for cancer.

Claremont Creek Ventures is a venture capital firm investing in early stage information technology companies. Claremont Creek Ventures is based in Oakland. It is the premier funding source for early stage technology opportunities in the local area.

Relypsa is a biopharmaceutical company leading the discovery, development and commercialization of polymer-based medicines to treat conditions that are often overlooked and undertreated, but that can have a serious impact on patient lives or even be life-threatening.

Geron is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

Vir brings together cutting-edge innovations with leading scientific expertise and management to take on some of the world’s most challenging infectious diseases for which solutions are non-existent or inadequate.

Catalyst is a clinical-stage biopharmaceutical company leveraging exceptional science to discover and develop essential medicines.

LTC is a real estate investment trust that invests in private pay seniors housing and healthcare properties. The company’s portfolio currently includes over 200 assisted living, memory care, skilled nursing and range-of-care facilities in over 30 states.